Anika Therapeutics, Inc. SEC filings ANIK

Anika Therapeutics, Inc. has 1,004 filings in SEC EDGAR's recent list, going back to Dec 19, 2003. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 29, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Anika Therapeutics, Inc. SEC filings
Form Description Filed Period
DEFA14A Additional proxy material Jun 8, 2026 —
DEFA14A Additional proxy material Jun 1, 2026 —
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 18, 2026
DEFA14A Additional proxy material Apr 28, 2025 —
DEF 14A Proxy statement Apr 28, 2025 Jun 20, 2025
DEFA14A Additional proxy material Jun 25, 2024 —
DEF 14A Proxy statement Jun 11, 2024 Jul 9, 2024
DEFA14A Additional proxy material May 1, 2023 —
DEF 14A Proxy statement May 1, 2023 —
DEFA14A Additional proxy material Mar 27, 2023 —
DEFA14A Additional proxy material Jun 3, 2022 —
DEFA14A Additional proxy material Jun 1, 2022 —
DEFA14A Additional proxy material May 9, 2022 —
DEF 14A Proxy statement Apr 27, 2022 Jun 8, 2022
DEFA14A Additional proxy material Apr 27, 2022 —
DEFA14A Additional proxy material Apr 30, 2021 —
DEF 14A Proxy statement Apr 30, 2021 Jun 16, 2021
DEFA14A Additional proxy material Apr 29, 2020 —
DEF 14A Proxy statement Apr 29, 2020 Jun 16, 2020
DEFA14A Additional proxy material Apr 25, 2019 —
DEF 14A Proxy statement Apr 25, 2019 Jun 18, 2019
DEFA14A Additional proxy material Apr 17, 2018 —
DEF 14A Proxy statement Apr 17, 2018 May 31, 2018
PRE 14A Preliminary proxy statement Apr 6, 2018 May 31, 2018
DEFA14A Additional proxy material Apr 28, 2017 —
DEF 14A Proxy statement Apr 28, 2017 Jun 13, 2017
DEFA14A Additional proxy material Apr 20, 2016 —
DEF 14A Proxy statement Apr 20, 2016 Jun 1, 2016
PRE 14A Preliminary proxy statement Apr 6, 2016 Jun 1, 2016
DEFA14A Additional proxy material Apr 24, 2015 —
DEF 14A Proxy statement Apr 23, 2015 Jun 3, 2015
DEF 14A Proxy statement Apr 23, 2015 Jun 3, 2015
DEFA14A Additional proxy material Apr 23, 2014 —
DEF 14A Proxy statement Apr 23, 2014 Jun 5, 2014
DEFA14A Additional proxy material Apr 23, 2013 —
DEF 14A Proxy statement Apr 23, 2013 Jun 18, 2013
DEFA14A Additional proxy material Apr 25, 2012 —
DEF 14A Proxy statement Apr 25, 2012 Jun 7, 2012
DEFA14A Additional proxy material May 20, 2011 —
DEFA14A Additional proxy material Apr 28, 2011 —
DEF 14A Proxy statement Apr 28, 2011 Jun 7, 2011
DEFA14A Additional proxy material Apr 22, 2010 —
DEF 14A Proxy statement Apr 22, 2010 Jun 3, 2010
DEFA14A Additional proxy material May 29, 2009 —
DEF 14A Proxy statement Apr 28, 2009 Jun 5, 2009
DEF 14A Proxy statement Apr 25, 2008 Jun 3, 2008
DEF 14A Proxy statement Apr 27, 2007 Jun 1, 2007
DEF 14A Proxy statement Apr 24, 2006 Jun 1, 2006
DEF 14A Proxy statement Apr 29, 2005 Jun 1, 2005
DEF 14A Proxy statement Apr 29, 2004 Jun 10, 2004

Showing 51 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
ANIK (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Bedford, MA
SEC filer status
Accelerated filer
SEC CIK
898437
Former names
ANIKA THERAPEUTICS INC (until Mar 13, 2014); ANIKA RESEARCH INC (until Nov 27, 1996)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.